Medicines Control Council
Registration of Medicines Reporting of Post-Marketing ADRs 2.33_ADR_reporting_post-marketing_Jul16_v4.1_showing_changes.doc Nov 2016 Page 1 of 22 MEDICINES CONTROL COUNCIL
Download Medicines Control Council
Information
Domain:
Source:
Link to this page:
Documents from same domain
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines CMs DS Safety & Efficacy 7.01_CMs_SE_DS_Jun16_v3.doc June 2016 Page 5 of 46 Back to ToC The CMs that will be the subject to these Guidelines are those associated with those disciplines as
Medicines Control Council
www.mccza.comRegistration of Medicines Reporting of Adverse Drug Reactions 2.11_ADR_reporting_May03_v1_2.doc December 2012 Page 4 of 18 1 INTRODUCTION The following guidelines pertain to Regulations 34 and 37 of Act 90 of 1997 [the Medicines and Related
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines General Information 2.01_General_information_Jul12_v8_showing_changes.docx PageAugust 2012 1 of 34 MEDICINES CONTROL COUNCIL GENERAL INFORMATION
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.com1997 . Version 1 - Chapter 9 (Validation) reformatted : January 2004 . Version 2 - Sept 2005 adopted PIC/S GMP Guide of July 2004 - Implementation : January 2006
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comImplementation. 1997 . Version 1 . Chapter 9 (Validation) reformatted : January 2004. Version 2 . Adoption of PIC/S GMP Guide of July 2004 : January 2006
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines CMs ZACTD 7.03_CAMs_ZACTD_Jun16_v3.docx June 2016 Page1 of 11 MEDICINES CONTROL COUNCIL COMPLEMENTARY MEDICINES - USE OF THE ZA-CTD FORMAT IN THE PREPARATION
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines Table of Contents: Guidelines and Forms . 1.01_Contents_May18_v6.docx May 2018 . Page 2 of 7. 2.31 Fixed Dose Combination Products for HIV/Aids, Tuberculosis, and Malaria
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comAdministration Notification of Registration of Medicines 12.52 Notification of Registration Apr10v1.doc May 2010 Page 1 of 4 MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comRegistration of Medicines Biosimilars . MEDICINES CONTROL COUNCIL. BIOSIMILAR MEDICINES QUALITY, NON-CLINICAL AND CLINICAL REQUIREMENTS
MEDICINES CONTROL COUNCIL - mccza.com
www.mccza.comThis guideline is intended to provide to applicants on the scheduling of substances submitted for registration guidance as medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines and
Related documents
Pharmacovigilance Systems ANALYSIS in Five …
apps.who.int2 comparative analysis of pharmacovigilance systems in five asian countries This report is made possible through an interagency agreement between the US Food and Drug Administration (FDA)
Guidelines on Similar Biologic: Regulatory …
www.cdsco.nic.inGuidelines on Similar Biologic: Regulatory Requirements for Marketing Authorization in India
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VI EMA/873138/2011 Page 2/84 9
Post-marketing Surveillance of Drugs - JPMA
www.jpma.or.jp73 CHAPTER 4 Post-marketing Surveillance of Drugs . Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and
WHO Drug Information
www.who.int575 WHO Drug Information Vol. 31, No. 4, 2017 Safety of medicines Priming resource-limited countries for pharmacovigilance “Project 3-S”: Smart Safety Surveillance for priority medical products